FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely to therapy and endocrinology, and concerns diagnosis of prediabetes and type 2 diabetes (DM2) in obese men. That is ensured by determining the level of the insulin resistance index HOMA-IR, the content of the main pro-inflammatory cytokines in the blood - TNF-α and IL-6, derived data are used to calculate prognostic coefficients of prediabetes -P1 and type 2 diabetes of type -P2 based on the developed formulas.
EFFECT: method enables high-accuracy diagnosis of carbohydrate metabolism disturbance and, accordingly, adequate and timely correction.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MONITORING INDIVIDUALS WITH RISK OF EARLY ATHEROSCLEROSIS AND SUFFERING FROM TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2533836C1 |
| METHOD OF DIAGNOSING DISTURBANCE OF TOLERANCE TO GLUCOSE AND DIABETES MELLITUS | 2009 |
|
RU2408287C1 |
| METHOD OF TREATING PATIENTS WITH METABOLIC SYNDROME | 2018 |
|
RU2699508C1 |
| METHOD FOR EARLY DIAGNOSIS OF INSULIN RESISTANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2019 |
|
RU2740587C1 |
| METHOD FOR TREATING PREDIABETES IN PERSONS WITH EXTERNAL EATING BEHAVIOR | 2022 |
|
RU2805361C1 |
| SYNBIOTIC COMPOSITION FOR DISORDER PREVENTION | 2018 |
|
RU2773458C2 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING VASCULAR LESIONS AT EARLY STAGES OF CARBOHYDRATE METABOLISM DISORDERS | 2019 |
|
RU2735706C1 |
| METHOD OF TREATING NONALCOHOLIC FATTY LIVER DISEASE WITH USE OF PENTOXIFYLLINE AMPLI-PULSE PHORESIS | 2014 |
|
RU2548775C1 |
| METHOD OF ESTIMATING RISK OF METABOLIC SYNDROME DEVELOPMENT IN CHILDREN BASING ON GENETIC AND BIOCHEMICAL MARKERS | 2012 |
|
RU2492485C1 |
| METHOD FOR DIAGNOSING INSULIN RESISTANCE IN PATIENTS WITH TYPE 1 DIABETES MELLITUS | 2024 |
|
RU2825046C1 |
